Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Udenafil in adolescents after Fontan surgery did not significantly improve oxygen consumption at ...
Dr Julian Alexander Härtel and Dr Nicole Müller from the Department of Paediatric Cardiology at the UKB, who jointly led the study, with study nurse and coordinator Ute Baur. The researchers conducted ...
Melissa Lyle, MD: Hello, everyone. I am Melissa Lyle, cardiology fellow at Mayo Clinic. Today, we will be discussing the management of Fontan patients. I am joined by my colleagues, Dr Alexander Egbe ...
Please provide your email address to receive an email when new articles are posted on . Patients with congenital heart disease and Fontan physiology had a high prevalence of chronic venous ...
The letter by Asrani et al. (May 2 issue) 1 reports cases of hepatocellular carcinoma in patients who have undergone Fontan palliation for univentricular hearts. Our practice includes yearly screening ...
An elevated body mass index (BMI) in childhood is a significant risk factor for cardiovascular disease, and it may pose an additional risk to children and adults with palliated univentricular ...
SEOUL, South Korea and BETHESDA, Md., June 22, 2018 /PRNewswire/ -- Mezzion Pharma and the National Heart, Lung, and Blood Institute (NHLBI) today announced that it has completed enrollment of their ...
Lungs Heart The NDA submission is supported by data from more than 200 studies completed over the last 2 decades, including the pivotal phase 3 FUEL trial. The Food and Drug Administration (FDA) has ...
Mezzion Pharma Submits Protocol for Confirmatory Pivotal Phase 3 Trial ("FUEL-2") in Fontan Subjects
SEOUL, South Korea, Feb. 21, 2023 /PRNewswire/ -- Mezzion Pharma Co., Ltd. (Mezzion Pharma) has submitted a confirmatory pivotal Phase 3 Clinical Trial in Fontan subjects to the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results